当前位置:首页 - 行情中心 - 新天药业(002873) - 财务分析 - 现金流量表

新天药业

(002873)

  

流通市值:17.67亿  总市值:17.99亿
流通股本:2.40亿   总股本:2.44亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金617,294,349.8409,070,694.98193,945,838.87833,960,084.71
  收到其他与经营活动有关的现金12,050,423.117,545,576.616,144,559.0518,130,532.43
  经营活动现金流入小计629,344,772.91416,616,271.59200,090,397.92852,090,617.14
  购买商品、接受劳务支付的现金55,243,161.1239,030,882.1826,470,792.42172,053,509.75
  支付给职工以及为职工支付的现金235,318,574.27164,676,102.8682,178,719.89321,825,937.37
  支付的各项税费55,527,457.7335,308,000.112,493,679.3686,325,895.41
  支付其他与经营活动有关的现金107,134,248.3967,562,590.5235,328,479.11188,150,532.28
  经营活动现金流出小计453,223,441.51306,577,575.66156,471,670.78768,355,874.81
  经营活动产生的现金流量净额176,121,331.4110,038,695.9343,618,727.1483,734,742.33
二、投资活动产生的现金流量:
  收回投资收到的现金15,069,275.5115,000,00015,000,00015,000,257.5
  取得投资收益收到的现金15,867.67--7,132.6
  处置固定资产、无形资产和其他长期资产收回的现金净额2,131,50021,500-2,141,800
  投资活动现金流入小计17,216,643.1815,021,50015,000,00017,149,190.1
  购建固定资产、无形资产和其他长期资产支付的现金44,000,340.2238,570,173.3819,935,053.4851,593,456.15
  投资支付的现金15,000,00015,000,00015,000,00055,000,000
  取得子公司及其他营业单位支付的现金4,924,330.624,414,891.58-2,987,860.4
  投资活动现金流出小计63,924,670.8457,985,064.9634,935,053.48109,581,316.55
  投资活动产生的现金流量净额-46,708,027.66-42,963,564.96-19,935,053.48-92,432,126.45
三、筹资活动产生的现金流量:
  吸收投资收到的现金24,562,458.8824,562,458.88--
  取得借款收到的现金285,331,109.9155,457,50023,612,500532,750,971.36
  收到其他与筹资活动有关的现金432,710.57213,299.6--
  筹资活动现金流入小计310,326,279.35180,233,258.4823,612,500532,750,971.36
  偿还债务支付的现金394,825,000220,200,00048,280,000421,630,000
  分配股利、利润或偿付利息支付的现金20,146,413.1515,939,342.044,401,690.5441,423,807.85
  支付其他与筹资活动有关的现金3,790,358.442,475,072.21,208,857.125,444,632.47
  筹资活动现金流出小计418,761,771.59238,614,414.2453,890,547.66468,498,440.32
  筹资活动产生的现金流量净额-108,435,492.24-58,381,155.76-30,278,047.6664,252,531.04
五、现金及现金等价物净增加额20,977,811.58,693,975.21-6,594,37455,555,146.92
  加:期初现金及现金等价物余额173,719,574.8173,719,574.8173,719,574.8118,164,427.88
  期末现金及现金等价物余额194,697,386.3182,413,550.01167,125,200.8173,719,574.8
补充资料:
  净利润-4,861,436.22-9,111,475.81
  资产减值准备-336,811.71-1,596,751.68
  固定资产和投资性房地产折旧-14,215,270.5-28,028,678.8
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,215,270.5-28,028,678.8
  无形资产摊销-3,738,727.27-6,602,123.2
  长期待摊费用摊销-1,488,665.22-5,051,220.48
  处置固定资产、无形资产和其他长期资产的损失---781,861.48
  固定资产报废损失-70,811.68-159,963.5
  公允价值变动损失-36,009.78-21,808.74
  财务费用-8,912,121.09-18,439,755.67
  投资损失--112,264.15--6,728.87
  递延所得税-724,045.95-539,117.04
  其中:递延所得税资产减少-788,371.48-1,029,700.95
    递延所得税负债增加--64,325.53--490,583.91
  存货的减少-18,891,180.13--30,233,127.94
  经营性应收项目的减少-76,914,039.48-49,947,874.71
  经营性应付项目的增加--22,277,306.47--11,107,269.95
  不涉及现金收支的投资和筹资活动金额其他项目-1,362,562.87-3,029,257.34
  现金的期末余额-182,413,550.01-173,719,574.8
  减:现金的期初余额-173,719,574.8-118,164,427.88
  现金及现金等价物的净增加额-8,693,975.21-55,555,146.92
公告日期2026-10-292026-08-262026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑